Daniel C. Clupper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel C. Clupper has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
J. J. Mecholsky
University of Florida
3 shared publicationsD. C. Greenspan
U. S. Biomaterials Corp., Alachua, Florida
2 shared publicationsG. P. LaTorre
U. S. Biomaterials Corp., Alachua, Florida
2 shared publicationsDavid C. Greenspan
1 shared publicationGuy P. LaTorre
1 shared publicationJohn J. Mecholsky
1 shared publication
Latest Publications
- 1 June 2002
- Published by Elsevier in Biomaterials
- Vol. 23 (12) , 2599-2606
Bioactivity of tape cast and sintered bioactive glass-ceramic in simulated body fluid
- 1 June 2002
- Published by Elsevier in Biomaterials
- Vol. 23 (12) , 2599-2606
Bioactivity of tape cast and sintered bioactive glass-ceramic in simulated body fluid
- 1 October 2001
- Published by Springer Nature in Journal of Materials Science Letters
- Vol. 20 (20) , 1885-1888
Toughening of tape cast Bioglass® by lamination with stainless steel 316L
- 1 October 2001
- Published by Springer Nature in Journal of Materials Science Letters
- Vol. 20 (20) , 1885-1888
Toughening of tape cast Bioglass® by lamination with stainless steel 316L
- 29 August 2001
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 57 (4) , 532-540
Sintering temperature effects on the in vitro bioactive response of tape cast and sintered bioactive glass-ceramic in Tris buffer
Tape casting procedures were used to form thin polymeric sheets (100 μm thickness) loaded with bioactive glass particulate. Blanks were punched from the sheets, stacked, laminated, and heated in air to 500°C to remove the organic phase. The resulting bioactive glass discs were sintered at 800°C, 900°C, or 1000°C. Because the material is built up in layers and can be machined in the green state, such a processing technique can be used to form complex-shaped materials. The in vitro bioactivity of the tape cast sintered (TCS) bioactive glass-ceramic discs was then assessed in Tris buffer. The sample surface area to volume buffer (SA/V) ratio was approximately 0.1 cm2/mL. Tape cast bioactive glass-ceramic sintered at 900°C and 1000°C formed crystalline hydroxyapatite layers after 24 h in Tris buffer as indicated by FTIR, SEM, and EDS analysis. Decreasing the SA/V ratio to 0.013 cm2/mL allowed for the formation of crystalline hydroxyapatite layers on the surface of 800C TCS bioactive glass-ceramic. Given the dependence of the bioactive response as a function of the processing schedule and SA/V ratio, it may be possible to tailor the response to that desired in vivo or in vitro for tissue engineering studies. Biaxial flexural strength of TCS bioactive glass-ceramic increased with increasing sintering temperature. Strength of samples sintered at 1000°C for 3 h increased from 87 to 120 MPa after 2 weeks’ immersion in Tris buffer. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 532–540, 2001
- 29 August 2001
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 57 (4) , 532-540
Sintering temperature effects on the in vitro bioactive response of tape cast and sintered bioactive glass-ceramic in Tris buffer
Tape casting procedures were used to form thin polymeric sheets (100 μm thickness) loaded with bioactive glass particulate. Blanks were punched from the sheets, stacked, laminated, and heated in air to 500°C to remove the organic phase. The resulting bioactive glass discs were sintered at 800°C, 900°C, or 1000°C. Because the material is built up in layers and can be machined in the green state, such a processing technique can be used to form complex-shaped materials. The in vitro bioactivity of the tape cast sintered (TCS) bioactive glass-ceramic discs was then assessed in Tris buffer. The sample surface area to volume buffer (SA/V) ratio was approximately 0.1 cm2/mL. Tape cast bioactive glass-ceramic sintered at 900°C and 1000°C formed crystalline hydroxyapatite layers after 24 h in Tris buffer as indicated by FTIR, SEM, and EDS analysis. Decreasing the SA/V ratio to 0.013 cm2/mL allowed for the formation of crystalline hydroxyapatite layers on the surface of 800C TCS bioactive glass-ceramic. Given the dependence of the bioactive response as a function of the processing schedule and SA/V ratio, it may be possible to tailor the response to that desired in vivo or in vitro for tissue engineering studies. Biaxial flexural strength of TCS bioactive glass-ceramic increased with increasing sintering temperature. Strength of samples sintered at 1000°C for 3 h increased from 87 to 120 MPa after 2 weeks’ immersion in Tris buffer. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 532–540, 2001
- 1 May 2001
- Published by Springer Nature in Journal of Materials Science Letters
- Vol. 20 (10) , 959-960
Bioactivity of Bioglass®-steel and Bioglass®-titanium laminate composites
- 1 May 2001
- Published by Springer Nature in Journal of Materials Science Letters
- Vol. 20 (10) , 959-960
Bioactivity of Bioglass®-steel and Bioglass®-titanium laminate composites